Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study was to investigate the effects of digital pelvic floor muscle training and lifestyle recommendations in patients with Multiple Sclerosis having lower urinary tract symptoms.
Multiple sclerosis (MS) is an autoimmune, neurodegenerative disease of the central nervous system. Lower urinary tract symptoms (LUTS) are very common in MS. Pelvic floor muscle training (PFMT) is one of the first-line choices for the conservative treatment of LUTS.
According to our knowledge, no study has investigated the effects of digital pelvic floor muscle training and lifestyle recommendations in MS having LUTS, yet.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Exercise group | Experimental | Lifestyle recommendations as well as digital pelvic floor muscle training to the exercise group |
|
| Control group | Active Comparator | Lifestyle recommendations will be given to the control group |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Exercise | Other | Pelvic floor muscle training program planned under the supervision of a physiotherapist was applied and followed to the exercise group, using the digital application. |
| Measure | Description | Time Frame |
|---|---|---|
| Incontinence symtoms | Urinary incontinence symptoms will be evaluated with The International Consultation of Incontinence Questionnaire - Short Form | change from baseline at 8 weeks |
| Overactive bladder symptoms | Overactive bladder symptoms will be evaluated with Overactive Bladder Questionnaire-Version8 | change from baseline at 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| bladder functions | bladder functions will be evaluated with voiding diary | change from baseline at 8 weeks |
| Quality of life level | Quality of life will be evaluated with King's Health Questionnaire |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Seyda Toprak Celenay | Contact | +90312 906 1000 | sydtoprak@hotmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Seyda Toprak Celenay | Ankara Yildirim Beyazıt University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ankara Yildirim Beyazit University | Ankara | Turkey (Türkiye) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D059411 | Lower Urinary Tract Symptoms |
| D009103 | Multiple Sclerosis |
| ID | Term |
|---|---|
| D020924 | Urological Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D020278 | Demyelinating Autoimmune Diseases, CNS |
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
Participants will be randomly divided into two groups (control and exercise) for treatment.
Not provided
Not provided
Not provided
Not provided
| Lifestyle recommendations | Other | Information was given within the scope of lifestyle recommendations (fluid intake, diet, constipation, weight control, smoking related to lower urinary system symptoms |
|
| change from baseline at 8 weeks |
| subjective perception of improvement | subjective perception of improvement will be evaluated with a 4-item Likert-type scale | after treatment (8th week) |
| patient satisfaction | patient satisfaction will be evaluated with a 5-item Likert-type scale | after treatment (8th week) |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D003711 | Demyelinating Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |